These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 27074098)

  • 41. Construction of nanoscale multicompartment liposomes for combinatory drug delivery.
    Al-Jamal WT; Kostarelos K
    Int J Pharm; 2007 Mar; 331(2):182-5. PubMed ID: 17223294
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nanocarrier systems for oral drug delivery: do we really need them?
    Bernkop-Schnürch A
    Eur J Pharm Sci; 2013 May; 49(2):272-7. PubMed ID: 23537503
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Trends in advanced oral drug delivery system for curcumin: A systematic review.
    Pan-On S; Dilokthornsakul P; Tiyaboonchai W
    J Control Release; 2022 Aug; 348():335-345. PubMed ID: 35654170
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of particulate drug delivery systems for oral delivery of Peptide and protein drugs.
    Christophersen PC; Fano M; Saaby L; Yang M; Nielsen HM; Mu H
    Curr Pharm Des; 2015; 21(19):2611-28. PubMed ID: 25876916
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A photodependent switch of liposome stability and permeability.
    Randles EG; Bergethon PR
    Langmuir; 2013 Feb; 29(5):1490-7. PubMed ID: 23286452
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Research progress of liposome drug delivery system in stomatology].
    Hu ZM; Liu SY; Yang HY; Huang C
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2021 Mar; 56(3):294-300. PubMed ID: 33663162
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Engineering lipid vesicles of enhanced intratumoral transport capabilities: correlating liposome characteristics with penetration into human prostate tumor spheroids.
    Kostarelos K; Emfietzoglou D; Papakostas A; Yang WH; Ballangrud AM; Sgouros G
    J Liposome Res; 2005; 15(1-2):15-27. PubMed ID: 16194925
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape.
    Zylberberg C; Matosevic S
    Drug Deliv; 2016 Nov; 23(9):3319-3329. PubMed ID: 27145899
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TPGS-chitosome as an effective oral delivery system for improving the bioavailability of Coenzyme Q10.
    Shao Y; Yang L; Han HK
    Eur J Pharm Biopharm; 2015 Jan; 89():339-46. PubMed ID: 25542680
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biotinylated liposomes as potential carriers for the oral delivery of insulin.
    Zhang X; Qi J; Lu Y; He W; Li X; Wu W
    Nanomedicine; 2014 Jan; 10(1):167-76. PubMed ID: 23891617
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interaction of curcumin with lipid monolayers and liposomal bilayers.
    Karewicz A; Bielska D; Gzyl-Malcher B; Kepczynski M; Lach R; Nowakowska M
    Colloids Surf B Biointerfaces; 2011 Nov; 88(1):231-9. PubMed ID: 21778041
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Composition design and medical application of liposomes.
    Li M; Du C; Guo N; Teng Y; Meng X; Sun H; Li S; Yu P; Galons H
    Eur J Med Chem; 2019 Feb; 164():640-653. PubMed ID: 30640028
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nanostructured lipid carriers used for oral delivery of oridonin: an effect of ligand modification on absorption.
    Zhou X; Zhang X; Ye Y; Zhang T; Wang H; Ma Z; Wu B
    Int J Pharm; 2015 Feb; 479(2):391-8. PubMed ID: 25556104
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Surface design of nanocarriers: Key to more efficient oral drug delivery systems.
    Spleis H; Sandmeier M; Claus V; Bernkop-Schnürch A
    Adv Colloid Interface Sci; 2023 Mar; 313():102848. PubMed ID: 36780780
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Application of surface-coated liposomes for oral delivery of peptide: effects of coating the liposome's surface on the GI transit of insulin.
    Iwanaga K; Ono S; Narioka K; Kakemi M; Morimoto K; Yamashita S; Namba Y; Oku N
    J Pharm Sci; 1999 Feb; 88(2):248-52. PubMed ID: 9950646
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lipid bilayer fragments and disks in drug delivery.
    Carmona-Ribeiro AM
    Curr Med Chem; 2006; 13(12):1359-70. PubMed ID: 16719782
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oral bioavailability enhancement of a hydrophilic drug delivered via folic acid-coupled liposomes in rats.
    Ling SS; Yuen KH; Magosso E; Barker SA
    J Pharm Pharmacol; 2009 Apr; 61(4):445-9. PubMed ID: 19298690
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Solubilisation of dipalmitoylphosphatidylcholine bilayers by sodium taurocholate: a model to study the stability of liposomes in the gastrointestinal tract and their mechanism of interaction with a model bile salt.
    Andrieux K; Forte L; Lesieur S; Paternostre M; Ollivon M; Grabielle-Madelmont C
    Eur J Pharm Biopharm; 2009 Feb; 71(2):346-55. PubMed ID: 18835441
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt.
    Chen Y; Lu Y; Chen J; Lai J; Sun J; Hu F; Wu W
    Int J Pharm; 2009 Jul; 376(1-2):153-60. PubMed ID: 19394416
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Updates on the use of liposomes for active tumor targeting in cancer therapy.
    Yan W; Leung SS; To KK
    Nanomedicine (Lond); 2020 Feb; 15(3):303-318. PubMed ID: 31802702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.